stockrow
Saturday 7 November 2026
Export SRTA’s income statement to Excel — free account
Strata Critical Medical, Inc.
SRTA Healthcare Medical Care Facilities
- Revenue
- +50.3%
- EPS
- −112.3%
- Free cash flow
- +121.3%
Quarter to September 2026, against a year earlier
5.57
0.31
+5.89%
Follow SRTA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
9.49 | 7.24 | 10.39 | 0.00 |
P/S ratio |
2.00 | 1.56 | 1.78 | 1.61 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(47.53) | 91.80 | 79.89 | 47.69 | |
P/B ratio |
1.41 | 1.25 | 1.63 | 1.63 | |
Price to Tangible BV |
2.75 | 2.36 | 4.04 | 3.90 | |
EV/Sales |
1.69 | 1.30 | 1.69 | 1.46 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 124.86 | |
EV/Operating CF |
(6.82) | (6.65) | (11.97) | 38.16 | |
EV/FCF |
(5.56) | (5.12) | (8.71) | (1,071.14) | |
Quick Ratio |
5.13 | 4.71 | 1.45 | 1.88 | |
Current Ratio |
6.38 | 5.93 | 2.64 | 2.77 | |
Net Debt/EBITDA |
18.10 | (686.66) | (7.41) | (12.04) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.68 | 0.79 | 0.87 | 0.85 | |
Operating CF/Net income |
0.94 | 1.80 | (0.54) | (1.24) | |
Capex/Depreciation |
(0.67) | (1.79) | (0.33) | (0.11) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
28.96% | 23.16% | 19.30% | 20.44% | |
Intangible Assets out of Total Assets |
0.42 | 0.41 | 0.50 | 0.49 | |
Share Based Compensation of Revenue |
9.86% | 7.47% | 5.11% | 6.82% | |
Graham Net Nets |
0.20 | 0.23 | 0.15 | 0.16 | |
Graham Number |
6.23 | 6.59 | 6.08 | 0.00 | |
Earnings Yield |
10.54% | 13.81% | 9.62% | (5.46%) | |
Free Cash Flow Yield |
(15.18%) | (16.30%) | (10.90%) | (0.08%) | |
Revenue per Share |
0.81 | 0.79 | 0.84 | 0.84 | |
Operating CF per Share |
(0.10) | 0.05 | 0.07 | 0.11 | |
Capex per Share |
(0.02) | (0.06) | (0.03) | (0.01) | |
Free Cash Flow per Share |
(0.13) | (0.02) | 0.03 | 0.10 | |
Cash per Share |
0.75 | 0.69 | 0.27 | 0.47 | |
Shareholders Equity per Share |
3.40 | 3.35 | 3.24 | 3.13 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.40 | 3.35 | 3.24 | 3.13 | |
Free Cash Flow |
(10.31) | (1.60) | 2.88 | 8.64 | |
Working Capital |
106.40 | 103.20 | 75.23 | 80.02 | |
Capital Expenditures |
(2.00) | (5.48) | (2.80) | (0.81) | |
Net Current Asset Value |
79.79 | 82.26 | 67.63 | 72.63 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.08 | 0.04 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
29.89 | 30.87 | 35.79 | 40.16 | |
Average Payables |
14.18 | 15.23 | 16.03 | 20.79 | |
Average Assets |
291.07 | 289.08 | 295.31 | 331.98 | |
Average Common Equity |
250.51 | 252.73 | 251.21 | 279.69 |
Columns are period end dates · fundamentals updated 5 Nov 2026